Abstract: The Japan Nurses' Health Study (JNHS) is a prospective occupational cohort study investigating the effects of lifestyle and healthcare practices on women's health. It was initiated in 2001, with a six-year entry period and a proposed ten-year follow-up. Participants comprise female registered nurses, licensed practical nurses, public health nurses, and midwives, aged 25 yr or over at the baseline survey. Participants were recruited in cooperation with the Japanese Nursing Association and the Japan Menopause Society. A self-administered baseline questionnaire was distributed, requesting demographic information, lifestyle factors, pharmaceutical drug use, physical condition, reproductive health, and disease history. A total of 49,914 women from all 47 prefectures in Japan responded to the baseline survey. Among them, approximately 18,000 agreed to be followedup, and returned signed informed-consent sheets, together with their completed baseline questionnaires. Changes in lifestyle, healthcare, incidence of disease, and health outcomes over time will now be studied. The cohort receives annual JNHS newsletters and biennial follow-up questionnaires by mail.
Introduction
Relatively few biomedical and epidemiological investigations have targeted women, although many genderspecific issues are associated with women's occupational health. Some large-scale prospective cohort studies focused on women's health between the 1970s and 1990s such as the Nurses' Health Study-I and -II 1, 2) , the Women's Health Initiative Study 3) , and the Million Women Study 4) . These investigations evaluated the effects of gender-specific and non-specific exposure issues such as exogenous hormones and cigarette smoke, respectively. Although these studies highlighted important women's health issues, many controversial issues remain, such as the use of hormone replacement therapy to prevent cardiovascular disease among postmenopausal women. Despite decades of evidence from observational epidemiological studies 5) , clinical trials in the Women's Health Initiative Study generated adverse results 6) . Such diversity indicates that the effectiveness of various healthcares might differ among various populations.
Epidemiological studies that provide comparable evidence of women's health have not been implemented in Japan. An epidemiological study is needed for Japanese women who may have a different lifestyle, working environment, and healthcare practice from women in other countries. We designed a prospective occupational cohort study of Japanese women based on the design of the Nurses' Health Study (NHS) that has contributed the most to women's health worldwide. We confirmed the feasibility of the research strategy in the 1999 Gunma Pilot Study 7) , and we initiated the Japan Nurses' Health Study (JNHS) in 2001. This paper describes the design of the JNHS and results obtained during the recruitment phase.
Subjects and Methods

Study design and purposes
The Japan Nurses' Health Study (JNHS), the Epidemiological Study of Lifestyle and Women's Health, is a prospective occupational cohort study that investigates the health of Japanese women. The study was initiated in 2001 and consists mainly of a cross-sectional baseline survey and longitudinal follow-up. The entry and follow-up periods are six and ten years, respectively. The primary purposes of the JNHS are to describe the status of lifestyle, healthcare practice, and physical status of Japanese women, to estimate the effects of those factors on their health, and to establish evidence regarding the risk-benefits of long-term administration of women-specific health management such as exogenous hormones use. The secondary purposes of the study are to investigate occupational health among Japanese nurses, and to evaluate the effects of shift work and work related stress on women's health.
Recruitment
In order to protect personal information of their members, the Japanese Nursing Association would not permit detailed sampling based on a register of nurses, as had been employed in the American NHS. Given these conditions, we announced recruitment to the study at conferences of the Japanese Nursing Association and the Japan Menopause Society, by advertisements in newsletters sent to members of the Japanese Nursing Association, by invitation letters to nurses in the health/medical institutes in cooperation with the prefectural Nursing Associations, and by invitation from the JNHS Recruitment Committee (see Appendix). Interested medical institutes or individual nurses requested baseline questionnaire sets from the JNHS coordination center by application postcard, facsimile, e-mail, or telephone. At some nurses' conferences and hospitals, we distributed the baseline questionnaire sets directly to individual nurses.
Inclusion criteria
The study population was designed for female registered nurses, licensed practical nurses, public health nurses, and/ or midwives, who were at least 30 yr of age and resident in Japan at the baseline survey. The age limit was reduced to 25 yr in 2005. Although the participants were all licensed to practice nursing in Japan, they were not necessarily working full-time in this role.
Baseline survey
The baseline questionnaire was distributed with an invitation letter, photographs of female hormonal drugs, and a stamped self-addressed envelope. Respondents completed their questionnaires, sealed the envelope, and mailed them back to the JNHS coordination center. Respondents who agreed to be followed-up for ten years provided their name and address, signed the informed consent sheet, and returned the information with their completed baseline questionnaire.
The questionnaire addressed personal information and occupation (birth date, birth place, marital status, education, nursing qualification, employment position, place of employment, history of shift work), physical indicators (current weight, weight at birth, weight at age 18, height, blood pressure, total serum cholesterol, HDL-cholesterol, FBS, HbA1c), periodical medical examination (breast cancer mammography and self-examination, stomach cancer, uterine cervical cancer, endometrial cancer), habit and lifestyle (smoking, alcohol consumption, physical exercise, food), history of reproductive health (menarche, sterility, pregnancy, pregnancy-induced toxemia, childbirth, menstrual cycle, menopause), use of female hormone agents (oral contraceptives, hormone replacement therapy, with drug identification from photographs), other drugs and supplements, medical history and family history of diseases (hypertension, diabetes, hypercholesterolemia, myocardial infarction, angina pectoris, stroke, transient cerebral ischemia, endometriosis, uterine myoma, cervical carcinoma, uterine cervical cancer, endometrial cancer, ovarian cancer, breast cancer, gastric cancer, colon-rectal cancer, osteoporosis), and so on.
Follow-up study
Participants to be followed-up for ten years comprised those who provided written informed consent and who legibly registered their name and personal correspondence address. They were then mailed the annual JNHS newsletter and biennial follow-up questionnaires. This newsletter updates participants on the progress of the study and includes new information about women's health. Each follow-up questionnaire inquired about changes in lifestyle, healthcare practice, incidence of disease, and health over the past two years. Participants who had changed their name or address during the follow-up notified the JNHS coordination center of such using a sealed, stamped, selfaddressed postcard. Maintaining a response rate in each follow-up survey is important. Individuals who did not respond to the first mailed questionnaire received a second mailing within 6 months. Subsequently, we mailed a third and fourth questionnaire to those who still did not respond. If the JNHS coordination center could not contact the participants by mail, the JNHS Follow-up Committee confirmed the migration and a new address with the resident registry of the corresponding local district and sent a questionnaire to the new address. The JNHS Follow-up Committee confirms any deaths through death certificates retrieved from the National Vital Statistics.
Endpoints of the follow-up study
Primary endpoints of the follow-up study are the incidence of breast cancer, endometrial cancer, ovarian cancer, colonrectal cancer, myocardial infarction, angina pectoris, stroke, gallstone disease, and lung embolism according to participant self-reports. All-cause death, death from cancers (breast, uterine cervical, endometrial, colon-rectal, stomach, gallbladder, and lung), and death from cardiovascular diseases (myocardial infarction, coronary heart disease, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage) identified by the death certificates from the National Vital Statistics are also primary endpoints. Secondary endpoints are self-reported diabetes, bone fracture, other cancers, endometriosis, uterine myoma, benign breast tumor, venous thrombosis, arterial thrombosis of the lower limbs, hypertension, and hypercholesterolemia. We also investigated the incidence of diseases such as osteoporosis, intestinal polyp, cataract, rheumatoid arthritis, connective tissue disease, hepatitis, thyroid disease, and systemic lupus erythematosus.
Sample size and statistical power
The sample size of the baseline survey was established at 50,000 women as described below. The statistical power was updated using the interim results of the cumulative incidence of target diseases in the baseline survey and has been presented elsewhere 8) . Assuming 0.0015/person-years as the incidence of target health events (breast cancer or endometrial cancer), ten years as average follow-up duration, 20% as the exposure proportion of study population, 1.3 as the relative risk, two-tailed alpha=0.05, and beta=0.20, then the follow-up study population should comprise 39,750 women. We estimated the proportion of followed-up women as 80% of the baseline survey participants. Consequently, the sample size was set at 50,000 for the baseline survey.
Ethics, confidentiality and data management
This project proceeded in accordance with international guidelines of Good Epidemiology Practice 9) and Japanese Ethical Guidelines for Epidemiological Research 10) . Institutional review boards of the Gunma University and the National Institute of Public Health reviewed and approved the study protocol. The JNHS Study Monitoring Committee that is independent of the JNHS research group also reviewed the research strategy and periodically monitors the study procedure (see Appendix). Participants were informed of the purposes and procedures of the study in the invitation letter at the time of the baseline survey. All the signed consent sheets sent to the JNHS coordination center were filed. Any participant can withdraw from the study at any time during the follow-up period by sending written notice to the coordination center. Completed questionnaires and personal information such as name and address are securely stored at the JNHS Coordination and Data Center and confidentially handled only by the JNHS personnel designated by the principal investigator. The data for statistical analysis are stored by trained staff in electronic files using a double-entry system, and are separate from the personal information files. Only a number identifies the participants in the data files used for statistical analysis. Range, logical, and missing checks are performed using the software SAS, according to the data management manuals prepared by the JNHS Data Management and Analysis Committee. If the automated check flags inconsistent information, the data are manually verified by trained data entry staff at the JNHS Data Center.
Validation of self-reported illnesses
The endpoints of the follow-up study are primarily selfreported illness and health events. We send confirmation questionnaires for selected diseases to women who report such in the follow-up questionnaires to determine details of diagnosis and treatment. The JNHS Validation Study Committee then seeks written permission from the participants to review medical records for specific diseases or to ask their attending physician about the diagnosis and administered treatment. The JNHS Validation Study Committee provides sub-study protocols and confirmation questionnaires for selected diseases.
Study organization
The JNHS was initiated in collaboration with the Japan Menopause Society, and a principal investigator with a Steering Committee administers the study (See Fig. 1 ). The organization presently (2007) comprises one center and six committees. An ad hoc Protocol Review Committee was struck during the protocol development phase. The Coordination and Data Center is located at the Epidemiological Research Office, School of Health Sciences, Gunma University. The Data Management and Analysis Committee control the data management procedure with study coordinators, data entry staff, and data analysts to ensure the data quality. The Follow-up Committee searches for missing women during the followup period by confirming the resident registry of the corresponding local district and mortality in the National Vital Statistics. The Validation Study Committee validates self-reported illness and exposure, and finalizes the incidence of diseases as endpoints of the follow-up study. The Nurses Committee supervises the recruitment and counsels about the development of questionnaires, especially from the viewpoint of the occupational health of nurses. Our recruitment committee cooperated with the 47 prefectural Nursing Associations and with recruitment advisers from the Japan Menopause Society for eight geographic regions to invite nurses to participate in the study. Independently of the study organization, the Study Monitoring Committee periodically monitors the study process, having a similar task force to the Data and Safety Monitoring Committee in mega clinical trials. We also have advisory group of researchers at the Harvard School of Public Health that has run a Nurses' Health Study 1, 2) for 30 yr.
Results
Recruitment of nurses
Subject recruitment including the collection of baseline questionnaires began in November 2001 and was completed in March 2007. A total of 49,914 women had responded to the baseline survey from all 47 prefectures in Japan by March 2007. We cannot characterize the response rate in a general sense, because the precise source population of the study is indefinable. Nevertheless, these 49,914 responses represent 45.4% of 110,000 copies of the baseline questionnaire that were actually printed and mailed from the JNHS Study coordination center, that is, 8.6% of 579,665 members of the Japan Nursing Association (Year 2005), or 0.104% of all 47.8 million Japanese females in the general population aged over 25 yr. Data entry of the baseline questionnaire, confirmation of signed acceptance of follow-up study, and mailing JNHS newsletter and follow-up questionnaires are currently in progress. Approximately 18,000 women provided written informed consent. Figure 2 shows the proportion of women registered by August 2006 compared with the female population aged Table 1 briefly summaries the characteristics of the respondents sent the baseline questionnaire by March 2006 including age at the baseline survey, nursing certification, history of shift work, and of smoking. The proportions of age groups of the women were 30's, 42.9%; 40's, 40.0%, and 50's, 16.4%. Only a few women were aged <30 or 60+ yr. Most women (80%) functioned as registered nurses and had worked rotating night shift work, and 16.9% women were current smokers.
Interim analysis of participant characteristics
Discussion
The JNHS is the first nationwide prospective cohort study to focus on the health of Japanese women. Since healthcare, such as the administration of female hormone agents at each stage of life and reproductive health problems are gender-specific, the JNHS will provide valuable epidemiological evidence of the risk-benefits of lifestyle and healthcare among Japanese women. The Gunma Pilot Study has already examined the feasibility of a prospective study of Japanese nurses using a self-administered questionnaire 6) . The nature of the study design has the following potential limitations. For example, nurses represent a unique occupational population that might be relatively healthier, physically more active at work, and have more understanding about health than the general female population. Nurses who voluntarily agree to longterm participation might be healthier than those who do not. Consequently, the prevalence of lifestyle exposure, healthcare practice, or disease among the JNHS population may not necessarily be generalized to other populations. However, the association between lifestyle/healthcare factors and health outcome obtained by comparing women who have been exposed or not to such factors in JNHS population would be applicable to the general female population of Japan, because the observed association does not depend on the prevalence of exposure.
Most primary endpoints of the study rely profoundly on self-reporting of the participants, which is another limitation. Nurses were preferred as the study population because they report medical information more accurately than broader samples of women 1) . They are more familiar with medical terms and more easily understand questions about diseases in the JNHS questionnaires. Moreover, for most diseases, self-reported information will be confirmed with additional questionnaires and medical records by the sub-studies implemented by the JNHS Validation Study Committee. The JNHS Follow-up Committee will confirm deaths using data from the National Vital Statistics. Such activities of the JNHS group will preserve the accuracy of the self-reported illness in the study.
Nurses should also report accurate exposure information of lifestyle and healthcare. For example, the general female population may not easily identify their administered pharmaceutical drugs in a community-based survey. However, nurses can readily identify drugs used for oral contraceptives or hormone replacement therapy, and the list of female hormonal agents with photographs should support the accuracy of the answers in the JNHS baseline survey. The study design of prospective observation should help to avoid recall bias and misclassification of exposure to various factors. The frequent observation of exposure by biennial questionnaires in the follow-up study and the inconsistency examination will reduce the misclassification of exposure to elements that could affect health. Compared with traditional community-based cohort studies in Japan, the JNHS is characterized by comprising only women aged from 25 to > 60 yr from a geographic area that encompasses all 47 prefectures of Japan. The JNHS should generate comprehensive current and useful information about the status of women's health in Japan. 
